Abstract
Non-transferrin bound iron (NTBI) is known to facilitate reactive oxygen species generation which contributes to the development of tissue damage observed in various disorders like hemolytic anemia, hemochromatosis, diabetes mellitus or many forms of neonatal central nervous system damage. Here we are summarizing information about biochemical nature of NTBI and review methods developed for its detection in biological material. Ability to detect NTBI concentration is likely to become an essential tool when it comes to diagnosis of diseases characterized by excessive iron accumulation. In contrast to routinely used parameters such as transferrin saturation or ferritin concentration, NTBI is not affected by inflammatory responses which makes it a reliable indicator. Unfortunately, we are still lacking validated laboratory methods to detect NTBI in biological fluids.
Keywords: Non-transferrin bound iron, Bleomycin, Nitrilotriacetic acid, Desferrioxamine, Hemochromatosis, Clinical Implications, Bacterial siderophore desferrioxamine (DFO), Myelodysplastic syndromes (MDS), Thalassemia
Current Pharmaceutical Analysis
Title: Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications
Volume: 7 Issue: 4
Author(s): Artur Slomka, Katarzyna Piotrowska, Marcin Koba and Ewa Zekanowska
Affiliation:
Keywords: Non-transferrin bound iron, Bleomycin, Nitrilotriacetic acid, Desferrioxamine, Hemochromatosis, Clinical Implications, Bacterial siderophore desferrioxamine (DFO), Myelodysplastic syndromes (MDS), Thalassemia
Abstract: Non-transferrin bound iron (NTBI) is known to facilitate reactive oxygen species generation which contributes to the development of tissue damage observed in various disorders like hemolytic anemia, hemochromatosis, diabetes mellitus or many forms of neonatal central nervous system damage. Here we are summarizing information about biochemical nature of NTBI and review methods developed for its detection in biological material. Ability to detect NTBI concentration is likely to become an essential tool when it comes to diagnosis of diseases characterized by excessive iron accumulation. In contrast to routinely used parameters such as transferrin saturation or ferritin concentration, NTBI is not affected by inflammatory responses which makes it a reliable indicator. Unfortunately, we are still lacking validated laboratory methods to detect NTBI in biological fluids.
Export Options
About this article
Cite this article as:
Slomka Artur, Piotrowska Katarzyna, Koba Marcin and Zekanowska Ewa, Non-Transferrin Bound Iron - Determination in Biological Material and Clinical Implications, Current Pharmaceutical Analysis 2011; 7 (4) . https://dx.doi.org/10.2174/157341211797458014
DOI https://dx.doi.org/10.2174/157341211797458014 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondria as Possible Pharmaceutical Targets for the Effects of Vitamin E and its Homologues in Oxidative Stress-Related Diseases
Current Pharmaceutical Design Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy
Current Alzheimer Research Burkholderia Cepacia Complex Causing Pneumonia in an Immunocompetent Non-Cystic Fibrosis Patient: Case Report and Review of Literature
Infectious Disorders - Drug Targets Chromium-Picolinate Therapy in Diabetes Care: Individual Outcomes Require New Guidelines and Navigation by Predictive Diagnostics
Infectious Disorders - Drug Targets The Role of PPARβ/δ in the Management of Metabolic Syndrome and its Associated Cardiovascular Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets The Molecular Concept of Atheromatous Plaques
Current Drug Targets Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway
Current Drug Targets Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among HIV Positive Patients in Tehran, Iran
Infectious Disorders - Drug Targets Role of the Sex Hormone Estrogen in the Prevention of Lipid Disorder
Current Medicinal Chemistry Genetics in Gestational Diabetes Mellitus: Association with Incidence, Severity, Pregnancy Outcome and Response to Treatment
Current Diabetes Reviews The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Hyperglycaemia and Vitamin D: A Systematic Overview
Current Diabetes Reviews Endless Pursuit: Evolution of Insulin Administration
Current Pharmaceutical Biotechnology WISP1 (CCN4) Autoregulates its Expression and Nuclear Trafficking of β-Catenin during Oxidant Stress with Limited Effects upon Neuronal Autophagy
Current Neurovascular Research Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies)
Current Pharmaceutical Design Mesenchymal Stem/Stromal Cells: A New "Cells as Drugs" Paradigm. Efficacy and Critical Aspects in Cell Therapy
Current Pharmaceutical Design Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders
Current Drug Targets Editorial [Hot Topic: Inhibition of the Renin-Angiotensin-Aldosterone System: How to Obtain This (Executive Guest Editors: Aldo Pende and Fabrizio Montecucco )]
Current Pharmaceutical Design A Prevention of Pre-eclampsia with the Use of Acetylsalicylic Acid and Low-molecular Weight Heparin – Molecular Mechanisms
Current Pharmaceutical Biotechnology Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital
Infectious Disorders - Drug Targets